CN102754831A - Formula of propolis, balsam pear and ginkgo leaf composite preparation with function of reducing blood sugar - Google Patents
Formula of propolis, balsam pear and ginkgo leaf composite preparation with function of reducing blood sugar Download PDFInfo
- Publication number
- CN102754831A CN102754831A CN2012102374804A CN201210237480A CN102754831A CN 102754831 A CN102754831 A CN 102754831A CN 2012102374804 A CN2012102374804 A CN 2012102374804A CN 201210237480 A CN201210237480 A CN 201210237480A CN 102754831 A CN102754831 A CN 102754831A
- Authority
- CN
- China
- Prior art keywords
- propolis
- blood sugar
- balsam pear
- grams
- ginkgo leaf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention provides a formula of a propolis, balsam pear and ginkgo leaf composite preparation with a function of reducing blood sugar. The formula comprises the following components in parts by mass: 50 to 60 parts of propolis, 60 to 70 parts of balsam pear extract, 45 to 55 parts of ginkgo leaf extract, and 0.1 to 0.3 part of chromium picolinate. The formula of the propolis, balsam pear and ginkgo leaf composite preparation with the function for reducing the blood sugar is used for assisting in reducing the blood sugar, and has a good effect and low side effect.
Description
Technical field
The present invention relates to health product technology field, particularly a kind of prescription with propolis, balsam pear and ginkgo leaf compound formulation of function of blood sugar reduction.
Background technology
Nowadays, the blood sugar height is a kind of common physical problems of people, and the harm that blood sugar is high is also well-known, but the general effect of health products of the various auxiliary reduction blood sugar that provides in the prior art is bad, and perhaps side effect is bigger, has influenced the effect that reduces blood sugar.
Summary of the invention
The present invention provides a kind of prescription with propolis, balsam pear and ginkgo leaf compound formulation of function of blood sugar reduction, and effective with auxiliary hyperglycemic, side effect is low.
To achieve these goals, the present invention provides following technical scheme:
A kind of prescription with propolis, balsam pear and ginkgo leaf compound formulation of function of blood sugar reduction, it comprises according to the mass fraction ratio: propolis 50-60 part, Bitter Melon P.E 60-70 part, ginkgo biloba p.e 45-55 part, chromium picolinate 0.1-0.3 part.
Preferably,, also comprise: corn oil 300-336 part, beeswax 10-20 part, gelatin 100-116 part, glycerine 50-58 part, iron oxide black 0.006-0.01 part, purified water 100-116 part according to the mass fraction ratio.
Through implementing above technical scheme, have following technique effect: the present invention provides the prescription of propolis, balsam pear and ginkgo leaf compound formulation with function of blood sugar reduction, with auxiliary hyperglycemic; Effective, side effect is low, according to the survey report of disease prevention and control center, Hunan Province: adopt counter point between own control and group; The volunteer that selection meets experiment condition took these health products 45 days, and former treatment diabetes kind and dosage are constant, and the result shows: taking these health products has the improvement effect to the diabetes main clinic symptoms; Total effective rate is 67.31% (control group is 15.38%); Compare after self relatively reaching the control group test-meal before and after the test-meal of test-meal group fasting blood-glucose, difference all has conspicuousness (P＜0.05), and test-meal group fasting blood-glucose fall and control group are relatively; Difference has conspicuousness (P＜0.05); And after the test-meal of fasting blood-glucose test-meal group than descending 10.20% before the test-meal, self relatively reach before test-meal group postprandial blood sugar and the test-meal with the control group test-meal after relatively, difference has conspicuousness (P＜0.05); After the test-meal of test-meal group postprandial blood sugar than descending 7.42% before the test-meal; Point out these health products to have the auxiliary function that reduces blood sugar, body weight, blood pressure, heart rate, routine blood test, routine urinalysis, stool routine examination and biochemical indicator detect and all do not see obvious abnormal change after the test-meal, do not find obvious adverse reaction during the test-meal.
The specific embodiment
Technical scheme is for a better understanding of the present invention described embodiment provided by the invention below in detail.
The embodiment of the invention provides a kind of prescription with propolis, balsam pear and ginkgo leaf compound formulation of function of blood sugar reduction; It comprises according to the mass fraction ratio: propolis 50-60 part, Bitter Melon P.E 60-70 part; Ginkgo biloba p.e 45-55 part, chromium picolinate 0.1-0.3 part.
Further among the embodiment, according to the mass fraction ratio, also comprise: corn oil 300-336 part, beeswax 10-20 part, gelatin 100-116 part, glycerine 50-58 part, iron oxide black 0.006-0.01 part, purified water 100-116 part.
Embodiment one:
Comprise: propolis 55 grams, ginkgo biloba p.e 50 grams, Bitter Melon P.E 65 grams, chromium picolinate 0.2 gram.Process 1,000 of soft capsules after mixing.
Embodiment two:
Comprise: propolis 55 grams, ginkgo biloba p.e 50 grams, Bitter Melon P.E 65 grams, chromium picolinate 0.2 gram; Corn oil 318 grams, beeswax 15 grams, gelatin 108 grams; Glycerine 54 grams, iron oxide black 0.006 gram, purified water 108 grams are processed 1,000 of soft capsules after mixing.
Embodiment three:
Comprise: propolis 60 grams, ginkgo biloba p.e 55 grams, Bitter Melon P.E 70 grams, chromium picolinate 0.1 gram; Corn oil 300 grams, beeswax 10 grams, gelatin 100 grams; Glycerine 50 grams, iron oxide black 0.008 gram, purified water 100 grams are processed 1,000 of soft capsules after mixing.
Embodiment four:
Comprise: propolis 50 grams, ginkgo biloba p.e 45 grams, Bitter Melon P.E 60 grams, chromium picolinate 0.3 gram, corn oil 336 grams, beeswax 20 grams, gelatin 116 grams, glycerine 58 grams, iron oxide black 0.01 gram, purified water 116 grams are processed 1,000 of soft capsules after mixing.
Embodiment five:
Comprise: comprising: propolis 60 grams, ginkgo biloba p.e 55 grams, Bitter Melon P.E 70 grams, chromium picolinate 0.1 gram is processed 1,000 of soft capsules after mixing.
Embodiment six:
Comprise: propolis 50 grams, ginkgo biloba p.e 45 grams, Bitter Melon P.E 60 grams, chromium picolinate 0.3 gram is processed 1,000 of soft capsules after mixing.
The propolis that uses among this embodiment: be the purifying propolis that common propolis obtains through alcohol extract, quality meets the requirement of appendix B in the declaration material 10 " propolis quality standard ".Be the traditional Chinese medicinal materials assortment that can be used for health food of Ministry of Public Health's approval, can be used as the raw material of health food.
Ginkgo biloba p.e, Bitter Melon P.E, ginkgo biloba p.e are the traditional Chinese medicinal materials assortment that can be used for health food of Ministry of Public Health approval, and Bitter Melon P.E is that " article in the healthy food material handbook all can be used as the raw material of health food.
Chromium picolinate: quality meets the requirement of appendix B in the declaration material 10 " chromium picolinate quality standard ", and chromium picolinate is that state's food medicine prison is annotated the article in [2005] No. 202 " vitamin, mineral cpd list ", can be as the raw material of health food.
Auxiliary material: corn oil: meet the requirement of GB 19111-2003 " corn oil ".
Beeswax: meet the requirement of SB/T 10190-1993 " beeswax ".
Gelatin: meet two " gelatin " items of Pharmacopoeia of the People's Republic of China version in 2005 related request down.
Glycerine: meet the requirement of GB 13206-1991 " glycerine ".
Iron oxide black: meet two " iron oxide black " requirements of Pharmacopoeia of the People's Republic of China version in 2005.
Purified water: meet two requirements of Pharmacopoeia of the People's Republic of China version in 2005.
These article are to the higher crowd of blood sugar.
Pharmacopeia regulation propolis consumption is 0.2-0.6g, and the consumption per day of propolis of the present invention is 0.33g.
Pharmacopeia regulation ginkgo leaf consumption is 9-12g, and these article are taken ginkgo biloba p.e 0.3g every day, amounts to crude drug and takes ginkgo leaf 2.4g every day.
Chinese medicine voluminous dictionary record balsam pear consumption 2-5 money, about 6-15g, take Bitter Melon P.E 0.39g every day of the present invention, amounts to crude drug and take balsam pear 3.9g every day.
State Food and Drug Administration's health food is evaluated the center publicity: for functional products such as auxiliary hyperglycemics, and chromium (Cr
3+) recommended intake maximum every day should not surpass 250ug, intake every day of chromium picolinate of the present invention is 149.2ug.
More than a kind of prescription with propolis, balsam pear and ginkgo leaf compound formulation of function of blood sugar reduction that the embodiment of the invention provided has been carried out detailed introduction; For one of ordinary skill in the art; Thought according to the embodiment of the invention; The part that on the specific embodiment and range of application, all can change, in sum, this description should not be construed as limitation of the present invention.
Claims (2)
1. the prescription with propolis, balsam pear and ginkgo leaf compound formulation of function of blood sugar reduction is characterized in that, according to the mass fraction ratio, comprising: propolis 50-60 part, Bitter Melon P.E 60-70 part, ginkgo biloba p.e 45-55 part, chromium picolinate 0.1-0.3 part.
2. the prescription that has propolis, balsam pear and the ginkgo leaf compound formulation of function of blood sugar reduction according to claim 1; It is characterized in that,, also comprise: corn oil 300-336 part according to the mass fraction ratio; Beeswax 10-20 part; Gelatin 100-116 part, glycerine 50-58 part, iron oxide black 0.006-0.01 part, purified water 100-116 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102374804A CN102754831A (en) | 2012-07-11 | 2012-07-11 | Formula of propolis, balsam pear and ginkgo leaf composite preparation with function of reducing blood sugar |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102374804A CN102754831A (en) | 2012-07-11 | 2012-07-11 | Formula of propolis, balsam pear and ginkgo leaf composite preparation with function of reducing blood sugar |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102754831A true CN102754831A (en) | 2012-10-31 |
Family
ID=47049674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012102374804A Pending CN102754831A (en) | 2012-07-11 | 2012-07-11 | Formula of propolis, balsam pear and ginkgo leaf composite preparation with function of reducing blood sugar |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102754831A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105533596A (en) * | 2015-12-14 | 2016-05-04 | 山东天地健生物工程有限公司 | Propolis, radix salviae miltiorrhizae and ginkgo leaf capsules and preparation method thereof |
| CN109045101A (en) * | 2018-09-26 | 2018-12-21 | 北京维特百草健康科技有限公司 | Chinese medicine composition and its application containing Chinese medical extract |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101637491A (en) * | 2009-06-10 | 2010-02-03 | 北京一品堂医药科技有限公司 | Health-care food having functions of assisting antidiabetics and assisting antiatheroscloresis preparation method thereof |
| CN101828660A (en) * | 2010-05-13 | 2010-09-15 | 山东森健生物科技发展有限公司 | Health-care food for hyperglycemia patient |
| CN101843308A (en) * | 2010-06-07 | 2010-09-29 | 杭州天厨蜜源保健品有限公司 | Propolis soft capsule and preparation method thereof |
| CN102178718A (en) * | 2011-04-20 | 2011-09-14 | 威海博力生物工程有限公司 | Preparation used for treating diabetes mellitus and preventively treating heart cerebrovascular disease |
-
2012
- 2012-07-11 CN CN2012102374804A patent/CN102754831A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101637491A (en) * | 2009-06-10 | 2010-02-03 | 北京一品堂医药科技有限公司 | Health-care food having functions of assisting antidiabetics and assisting antiatheroscloresis preparation method thereof |
| CN101828660A (en) * | 2010-05-13 | 2010-09-15 | 山东森健生物科技发展有限公司 | Health-care food for hyperglycemia patient |
| CN101843308A (en) * | 2010-06-07 | 2010-09-29 | 杭州天厨蜜源保健品有限公司 | Propolis soft capsule and preparation method thereof |
| CN102178718A (en) * | 2011-04-20 | 2011-09-14 | 威海博力生物工程有限公司 | Preparation used for treating diabetes mellitus and preventively treating heart cerebrovascular disease |
Non-Patent Citations (2)
| Title |
|---|
| 曾凡骏等: "辅助降血糖保健食品的研制", 《食品工业》 * |
| 王爱霞等: "蜂胶的降血糖作用研究现状", 《中国蜂业》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105533596A (en) * | 2015-12-14 | 2016-05-04 | 山东天地健生物工程有限公司 | Propolis, radix salviae miltiorrhizae and ginkgo leaf capsules and preparation method thereof |
| CN109045101A (en) * | 2018-09-26 | 2018-12-21 | 北京维特百草健康科技有限公司 | Chinese medicine composition and its application containing Chinese medical extract |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lazavi et al. | The barberry juice effects on metabolic factors and oxidative stress in patients with type 2 diabetes: a randomized clinical trial | |
| KR100778078B1 (en) | Pharmaceutical composition comprising the herbal mixture extracts of Cinnamomi Ramulus, Anemarrhenae Rhizoma and Alpinia Officinarum for preventing and treating inflammatory disease | |
| CN103987395B (en) | Contain the pharmaceutical composition that houttuynia extract is used to prevent and treat dull-witted, Parkinson's disease or epilepsy as active constituent | |
| Ardalani et al. | The Effect of Cynara scolymus on blood pressure and BMI in hypertensive patients: A randomized, double-blind, placebo-controlled, clinical trial | |
| CN101716182B (en) | Combined medicine containing metformin hydrochloride and vitamin B12 | |
| KR20140001961A (en) | Growth hormone secretion promoter | |
| US20150140112A1 (en) | Composition comprising extract of mixture of undaria pinnatifida sporophylls and ascidian shells for treating atopic dermatitis | |
| CN109758464A (en) | Application of Vietnam ginsenoside R4 in preparation neurodegenerative disease therapeutic agent | |
| KR20130064882A (en) | The composition for the prevention and treatment of diabetic or diabetic complications containing the extracts of herbal medicine | |
| Guo et al. | Analysis of anaphylactic shock caused by 17 types of traditional Chinese medicine injections used to treat cardiovascular and cerebrovascular diseases | |
| US20220133763A1 (en) | Composition containing nicotinamide mononucleotide and mogroside, and application thereof | |
| KR101336502B1 (en) | Novel use of rice bran extract or rice bran powder for improving, preventing or treating sleep disorders, anxiety, or depression | |
| CN107648297B (en) | Lonicera fulvidraco extract, preparation containing extract and application of extract in field of medicine | |
| NZ554762A (en) | Method of treating inflammation disorders using extracts of passion fruit | |
| CN102754831A (en) | Formula of propolis, balsam pear and ginkgo leaf composite preparation with function of reducing blood sugar | |
| CN107253960A (en) | Wild anistree new sesquilignan and preparation method thereof, using and pharmaceutical composition | |
| EP3403664B1 (en) | Use of cistanche tubulosa | |
| AU2018101586A4 (en) | Uses of polydatin | |
| KR102279105B1 (en) | Composition for preventing or treating renal disease comprising Zizyphus jujuba MILL extract | |
| CN114980882A (en) | Synergistic combination of cannabinoid and lycopene anti-inflammatory | |
| Kong et al. | Safety of individual medication of Ma Qian Zi (semen strychni) based upon assessment of therapeutic effects of Guo's therapy against moderate fluorosis of bone | |
| CN107693598A (en) | A kind of compound preparation of reducing blood lipid and preparation method thereof | |
| KR20210096121A (en) | Antidiabetic activity of neem extract and synergistic combination of urolitin A and B | |
| US20190343161A1 (en) | Therapeutic agent for chronic fatigue syndrome | |
| CN102726643A (en) | Formula of propolis, grape pip and folium ginkgo compound preparation with function of reducing blood fat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20121031 |